Showing results (281-290 of 338) with videos related to
Sort By:
Pageof 34
World Journal of Urology|January 11, 2026
Thermal injury and treatment efficiency during thulium fiber laser lithotripsy: insights from an in vivo porcine modelEzra J Margolin, Arpit Mishra, David L Barquin, et al.Cell Reports|December 8, 2016
Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor OutcomeXian Liu, Tristan R Grogan, Haley Hieronymus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate CancerRahul R Aggarwal, Jacqueline Vuky, David VanderWeele, et al.Proceedings of the National Academy of Sciences of the United States of America|March 23, 2021
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancerLingfan Xu, Yu Yin, Yanjing Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate CancerGanesh S Palapattu, Simpa S Salami, Andi K Cani, et al.Methods (San Diego, Calif.)|July 3, 2013
NanoVelcro Chip for CTC enumeration in prostate cancer patientsYi-Tsung Lu, Libo Zhao, Qinglin Shen, et al.Biorxiv : the Preprint Server for Biology|March 22, 2023
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cellsJason S Kirk, Jie Wang, Amanda Tracz, et al.Cell Stem Cell|June 15, 2024
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cellsJason S Kirk, Jie Wang, Mark Long, et al.Molecular Cancer Therapeutics|January 14, 2022
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to RadiationJake L Owens, Elena Beketova, Sheng Liu, et al.Nucleic Acids Research|April 13, 2021
Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancerChenxi Xu, Yi-Hsuan Tsai, Phillip M Galbo, et al.Pageof 34